Bristol Myers Squibb and Cellares reach $380 mln supply deal for CAR-T therapies-March 2024-www.financetom.com

Bristol Myers Squibb and Cellares reach $380 mln supply deal for CAR-T therapies

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Bristol Myers Squibb and Cellares reach $380 mln supply deal for CAR-T therapies

Apr 22, 2024 4:28 AM

April 22 (Reuters) - Bristol Myers Squibb ( BMY ) and

Cellares said on Monday they have reached a $380 million deal to

supply CAR-T cell therapies to more patients.

Previous page： A blue brighter than the sea and sky at the French Riviera Next page： Government should amend RBI Act if it needs surplus from previous years, says its former board member YH Malegam

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

A blue brighter than the sea and sky at the French Riviera

Nov 9, 2018

When the Eurorail curves around the hills and shows you the first glimpse of Cannes, you forget everything.

Government should amend RBI Act if it needs surplus from previous years, says its former board member YH Malegam

Nov 9, 2018

Reserve Bank of India (RBI) Act provides that all central bank's surplus in a year after provisions should go to the Centre.

DGCA asks IndiGo, GoAir to fix compressor problems in 15 engines

Nov 9, 2018

Aviation regulator DGCA asked IndiGo and GoAir to fix compressor issues in 15 engines following the latest airworthiness directive issued...

ITI Q2 net profit narrows to Rs 7.56 crore

Nov 11, 2018

The company's total revenue, however, rose to Rs 408.24 crore in the July-September quarter, from Rs 306.91 crore in the corresponding quarter of the previous year.